Page last updated: 2024-08-25

bromopyruvate and Pulmonary Arterial Hypertension

bromopyruvate has been researched along with Pulmonary Arterial Hypertension in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Liu, J; Qi, XM; Sha, YH; Wang, L; Wang, W; Yang, T1
Guo, Y; He, Y; Liu, X; Ouyang, F; Qiu, H; Zhang, Y1

Other Studies

2 other study(ies) available for bromopyruvate and Pulmonary Arterial Hypertension

ArticleYear
3-Bromopyruvate alleviates the development of monocrotaline-induced rat pulmonary arterial hypertension by decreasing aerobic glycolysis, inducing apoptosis, and suppressing inflammation.
    Chinese medical journal, 2020, Jan-05, Volume: 133, Issue:1

    Topics: Animals; Apoptosis; Blood Pressure; Blotting, Western; Cytochromes c; Fluorescent Antibody Technique; Glycolysis; Immunohistochemistry; In Situ Nick-End Labeling; Inflammation; Male; Monocrotaline; Pulmonary Arterial Hypertension; Pyruvates; Rats; Rats, Sprague-Dawley

2020
3-Bromopyruvate ameliorates pulmonary arterial hypertension by improving mitochondrial metabolism.
    Life sciences, 2020, Sep-01, Volume: 256

    Topics: Animals; Disease Models, Animal; Male; Mitochondria; Monocrotaline; Myocytes, Smooth Muscle; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Pulmonary Arterial Hypertension; Pulmonary Artery; Pyruvates; Rats; Rats, Sprague-Dawley; TOR Serine-Threonine Kinases

2020